These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4914821)

  • 1. Long-term follow-up of direct current cardioversion after cardiac surgery with special reference to quinidine.
    Gunning JF; Kristinsson A; Miller G; Saunders K
    Br Heart J; 1970 Jul; 32(4):462-6. PubMed ID: 4914821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.
    Södermark T; Jonsson B; Olsson A; Orö L; Wallin H; Edhag O; Sjögren A; Danielsson M; Rosenhamer G
    Br Heart J; 1975 May; 37(5):486-92. PubMed ID: 1093559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors predicting maintenance of sinus rhythm after direct current cardioversion of atrial fibrillation and flutter: a reanalysis with recently acquired data.
    Arnar DO; Danielsen R
    Cardiology; 1996; 87(3):181-8. PubMed ID: 8725311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of quinidine and disopyramide in the maintenance of sinus rhythm after electroconversion from atrial fibrillation. A double-blind study comparing quinidine, disopyramide and placebo.
    Lloyd EA; Gersh BJ; Forman R
    S Afr Med J; 1984 Mar; 65(10):367-9. PubMed ID: 6367096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.
    Nakazawa HK; Handa S; Nakamura Y; Oyanagi H; Hasegawa M; Ishikawa N; Ozaki O; Ito K
    Int J Cardiol; 1987 Jul; 16(1):47-55. PubMed ID: 3610396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of auricular fibrillation after correction of rheumatic heart disease under extracorporeal circulation].
    Konstantinov BA; Gromova GV; Alekseeva LA; Liudinovskova RA; Kulagina TI
    Kardiologiia; 1983 Feb; 23(2):77-81. PubMed ID: 6842953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation.
    Kirpizidis C; Stavrati A; Geleris P; Boudoulas H
    J Cardiol; 2001 Dec; 38(6):351-4. PubMed ID: 11806093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of sinus rhythm after DC reversion of atrial fibrilllation. A double-blind controlled trial of long-acting quinidine bisulphate.
    Byrne-Quinn E; Wing AJ
    Br Heart J; 1970 May; 32(3):370-6. PubMed ID: 4911757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians].
    Tebbe U; Carlsson J; Seidl K; Jansen W; Schuster HP; Elsner M; Neuhaus KL; Praetorius F
    Med Klin (Munich); 1995 Dec; 90(12):681-7. PubMed ID: 8583983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
    Kalusche D; Stockinger J; Betz P; Roskamm H
    Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of short-acting and long-acting quinidine for maintenance of sinus rhythm after electrical conversion of atrial fibrillation.
    Normand JP; Legendre M; Kahn JC; Bourdarias JP; Mathivat A
    Br Heart J; 1976 Apr; 38(4):381-7. PubMed ID: 773392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of sinus rhythm after atrial defibrillation.
    Szekely P; Sideris DA; Batson GA
    Br Heart J; 1970 Nov; 32(6):741-6. PubMed ID: 5212345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of very-low-dose amiodarone treatment for the maintenance of sinus rhythm in patients with chronic atrial fibrillation after successful direct-current cardioversion.
    Jong GP; Chang MH; Chang TC; Chou P; Fu CY; Tien LY; Chen CY; Ma TC
    Chin Med J (Engl); 2006 Dec; 119(24):2030-5. PubMed ID: 17199952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-energy internal cardioversion in patients with long-lasting atrial fibrillation refractory to external electrical cardioversion: results and long-term follow-up.
    Gasparini G; Bonso A; Themistoclakis S; Giada F; Raviele A
    Europace; 2001 Apr; 3(2):90-5. PubMed ID: 11333060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of rate versus rhythm in rheumatic atrial fibrillation: a randomized study.
    Vora A; Karnad D; Goyal V; Naik A; Gupta A; Lokhandwala Y; Kulkarni H; Singh B
    Indian Heart J; 2004; 56(2):110-6. PubMed ID: 15377131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled trial of a long-acting quinidine for maintenance of sinus rhythm after conversion of sustained atrial fibrillation.
    Boissel JP; Wolf E; Gillet J; Soubrane A; Cavallaro A; Mazoyer G; Delahaye JP
    Eur Heart J; 1981 Feb; 2(1):49-55. PubMed ID: 7274266
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
    Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
    Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term fate of 103 patients with auricular fibrillation lasting for over 15 days treated with cardioversion and preventive therapy].
    Roussane A; Blanc P; Virot P; Doumeix JJ; Chabanier A; Bensaid J; Blanc G
    Ann Cardiol Angeiol (Paris); 1984 Nov; 33(7):449-52. PubMed ID: 6508194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.